Pregled bibliografske jedinice broj: 1222851
Boron doxorubicin chitosan scaffolds as dual functional carriers with antitumor efficacy and bone regeneration ability
Boron doxorubicin chitosan scaffolds as dual functional carriers with antitumor efficacy and bone regeneration ability // Abstracts of Tissue Engineering and Regenerative Medicine International Society Asia‐Pacific Chapter Conference, Tissue Engineering Part A, Vol. 28, Issue S3
Seogwipo, Republika Koreja, 2022. str. 448-448 doi:10.1089/ten.tea.2022.29036.abstracts (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1222851 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Boron doxorubicin chitosan scaffolds as dual functional carriers with antitumor efficacy and bone regeneration ability
Autori
Dornjak, Luka ; Ostojić, Karla ; Kovačić, Marin ; Urlić, Inga ; Rogina, Anamarija
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of Tissue Engineering and Regenerative Medicine International Society Asia‐Pacific Chapter Conference, Tissue Engineering Part A, Vol. 28, Issue S3
/ - , 2022, 448-448
Skup
Tissue Engineering and Regenerative Medicine International Society – Asia‐Pacific Chapter Conference 2022 (TERMIS-AP 2022): New Chapter of Future Regenerative Medicine
Mjesto i datum
Seogwipo, Republika Koreja, 05.10.2022. - 08.10.2022
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
chitosan ; hydrogels ; boron ; doxorubicin ; sarcoma
Sažetak
Biologically compatible scaffolds have been considered as promising platforms for tissue regeneration, drug delivery and tumor treatments. Chitosan-based scaffolds can serve as pH-responsive drug carriers with targeted delivery resulting in less invasive tumor treatments. Going further, development of dual-functional carriers that will provide simultaneous antitumor efficacy and induce tissue regeneration through therapeutic ions can advance current tumor treatments. Here, boric acid-containing crosslinked chitosan scaffolds were prepared as pH-responsive carriers for doxorubicin, a chemotherapy drug used to treat tumors such as osteosarcoma, while simultaneously inducing bone regeneration through therapeutic effect of boron. The encapsulation of boric acid and doxorubicin was confirmed by FTIR and XRD analysis, while doxorubicin release from chitosan-based scaffold was evaluated in phosphate buffers of different pH (6.0 and 7.4) during 24 hours using HPLC method. The obtained scaffolds exhibit a highly porous and interconnected microstructure capable of high drug encapsulation efficiency. Due to chitosan’s polycationic nature, the obtained scaffolds exhibit higher swelling and drug release at lower pH characteristic for tumor microenvironment making them possible candidates for targeted drug delivery. The cytotoxicity of prepared doxorubicin carriers was evaluated on human sarcoma cells at pH 6.0 indicating proposed materials as cytotoxic agents.
Izvorni jezik
Engleski
Znanstvena područja
Kemijsko inženjerstvo, Temeljne tehničke znanosti, Interdisciplinarne tehničke znanosti
POVEZANOST RADA
Projekti:
HRZZ-UIP-2020-02-6201 - Pametni sustavi za dostavu lijeka pri liječenju tumora kosti (SmartCar) (Rogina, Anamarija, HRZZ - 2020-02) ( CroRIS)
Ustanove:
Prirodoslovno-matematički fakultet, Zagreb,
Fakultet kemijskog inženjerstva i tehnologije, Zagreb
Profili:
Anamarija Rogina
(autor)
Karla Ostojić
(autor)
Luka Dornjak
(autor)
Inga Urlić
(autor)
Marin Kovačić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE